• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

有卵巢癌家族史的女性在预防性卵巢切除术后发生原发性腹膜癌。吉尔达·拉德纳家族性卵巢癌登记处报告。

Primary peritoneal carcinoma after prophylactic oophorectomy in women with a family history of ovarian cancer. A report of the Gilda Radner Familial Ovarian Cancer Registry.

作者信息

Piver M S, Jishi M F, Tsukada Y, Nava G

机构信息

Department of Gynecologic Oncology, Roswell Park Cancer Institute, Buffalo, New York 14263.

出版信息

Cancer. 1993 May 1;71(9):2751-5. doi: 10.1002/1097-0142(19930501)71:9<2751::aid-cncr2820710911>3.0.co;2-j.

DOI:10.1002/1097-0142(19930501)71:9<2751::aid-cncr2820710911>3.0.co;2-j
PMID:8467455
Abstract

BACKGROUND

According to previous reports, primary peritoneal carcinoma indistinguishable from primary ovarian adenocarcinoma had developed in five women with a history of familial ovarian cancer who had undergone prophylactic oophorectomy.

METHODS

The records from the Gilda Radner Familial Ovarian Cancer Registry were reviewed for instances of prophylactic oophorectomy and cases of primary peritoneal carcinoma occurring after prophylactic oophorectomy.

RESULTS

From 1981 through July 1992, the Gilda Radner Familial Ovarian Cancer Registry accessioned 931 families (a total of 2221 cases of familial ovarian cancer). Currently, 324 women in these families have undergone prophylactic oophorectomy as a preventive measure against the subsequent development of ovarian cancer. Primary peritoneal carcinoma indistinguishable histologically from primary ovarian adenocarcinoma has developed in six of these women 1-27 years after prophylactic oophorectomy.

CONCLUSIONS

Based on this finding and other reports of such primary peritoneal carcinoma, a prospective international study is planned. This study will compare the incidence of peritoneal carcinoma in first- or second-degree relatives who underwent prophylactic oophorectomy because of a family history of ovarian cancer with that of those who did not undergo prophylactic oophorectomy.

摘要

背景

根据既往报道,5名有家族性卵巢癌病史且已接受预防性卵巢切除术的女性发生了与原发性卵巢腺癌难以鉴别的原发性腹膜癌。

方法

查阅吉尔达·拉德纳家族性卵巢癌登记处的记录,以了解预防性卵巢切除术的病例以及预防性卵巢切除术后发生原发性腹膜癌的病例。

结果

从1981年至1992年7月,吉尔达·拉德纳家族性卵巢癌登记处收纳了931个家族(共2221例家族性卵巢癌病例)。目前,这些家族中有324名女性已接受预防性卵巢切除术作为预防卵巢癌后续发生的措施。其中6名女性在预防性卵巢切除术后1至27年发生了组织学上与原发性卵巢腺癌难以鉴别的原发性腹膜癌。

结论

基于这一发现以及其他有关此类原发性腹膜癌的报道,计划开展一项前瞻性国际研究。该研究将比较因卵巢癌家族史而接受预防性卵巢切除术的一级或二级亲属与未接受预防性卵巢切除术的亲属中腹膜癌的发病率。

相似文献

1
Primary peritoneal carcinoma after prophylactic oophorectomy in women with a family history of ovarian cancer. A report of the Gilda Radner Familial Ovarian Cancer Registry.有卵巢癌家族史的女性在预防性卵巢切除术后发生原发性腹膜癌。吉尔达·拉德纳家族性卵巢癌登记处报告。
Cancer. 1993 May 1;71(9):2751-5. doi: 10.1002/1097-0142(19930501)71:9<2751::aid-cncr2820710911>3.0.co;2-j.
2
Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.预防性卵巢切除术:降低美国上皮性卵巢癌死亡率。一场持续的争论。
Oncologist. 1996;1(5):326-330.
3
Papillary peritoneal carcinomatosis after prophylactic oophorectomy.预防性卵巢切除术后的乳头状腹膜癌病
Gynecol Oncol. 1992 Dec;47(3):395-7. doi: 10.1016/0090-8258(92)90147-b.
4
Serous carcinoma of the peritoneum after oophorectomy.卵巢切除术后腹膜浆液性癌
Obstet Gynecol. 1992 Sep;80(3 Pt 2):558-60.
5
Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation.输卵管卵巢切除术与携带BRCA1或BRCA2基因突变女性患卵巢癌、输卵管癌和腹膜癌的风险
JAMA. 2006 Jul 12;296(2):185-92. doi: 10.1001/jama.296.2.185.
6
Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.BRCA1或BRCA2基因突变携带者的预防性卵巢切除术。
N Engl J Med. 2002 May 23;346(21):1616-22. doi: 10.1056/NEJMoa012158. Epub 2002 May 20.
7
Familial peritoneal ovarian carcinomatosis: a new clinical entity?家族性腹膜卵巢癌:一种新的临床实体?
Med Hypotheses. 1986 Oct;21(2):171-7. doi: 10.1016/0306-9877(86)90007-1.
8
Clinical outcome of prophylactic oophorectomy in BRCA1/BRCA2 mutation carriers and events during follow-up.BRCA1/BRCA2 基因突变携带者预防性卵巢切除术的临床结局及随访期间的事件
Br J Cancer. 2004 Apr 19;90(8):1492-7. doi: 10.1038/sj.bjc.6601692.
9
Peritoneal carcinoma in women with genetic susceptibility: implications for Jewish populations.具有遗传易感性的女性腹膜癌:对犹太人群的影响。
Fam Cancer. 2004;3(3-4):265-81. doi: 10.1007/s10689-004-9554-y.
10
Peritoneal carcinomatosis after prophylactic oophorectomy in familial ovarian cancer syndrome.家族性卵巢癌综合征患者预防性卵巢切除术后的腹膜癌转移
Obstet Gynecol. 1985 Sep;66(3 Suppl):93S-94S.

引用本文的文献

1
Incidence of peritoneal cancer after oophorectomy among BRCA1 and BRCA2 mutation carriers.BRCA1 和 BRCA2 基因突变携带者卵巢切除术后腹膜癌的发生率。
J Natl Cancer Inst. 2024 Nov 1;116(11):1753-1760. doi: 10.1093/jnci/djae151.
2
XIST lost induces ovarian cancer stem cells to acquire taxol resistance via a KMT2C-dependent way.XIST缺失通过一种依赖KMT2C的方式诱导卵巢癌干细胞获得紫杉醇耐药性。
Cancer Cell Int. 2020 Sep 4;20:436. doi: 10.1186/s12935-020-01500-8. eCollection 2020.
3
Risk-Reducing Salpingo-Oophorectomy and Breast Cancer Risk Reduction in the Gynecologic Oncology Group Protocol-0199 (GOG-0199).
妇科肿瘤学组0199方案(GOG-0199)中降低风险的输卵管卵巢切除术与降低乳腺癌风险
JNCI Cancer Spectr. 2019 Oct 10;4(1):pkz075. doi: 10.1093/jncics/pkz075. eCollection 2020 Feb.
4
Precision prophylaxis: Identifying the optimal timing for risk-reducing salpingo-oophorectomy based on type of BRCA1 and BRCA2 cluster region mutations.精准预防:基于 BRCA1 和 BRCA2 簇区域突变类型,确定行预防性输卵管卵巢切除术的最佳时机。
Gynecol Oncol. 2020 Feb;156(2):363-376. doi: 10.1016/j.ygyno.2019.11.036. Epub 2020 Jan 7.
5
Effect of Dexmedetomidine-Mediated Insulin-Like Growth Factor 2 (IGF2) Signal Pathway on Immune Function and Invasion and Migration of Cancer Cells in Rats with Ovarian Cancer.右美托咪定调控胰岛素样生长因子 2(IGF2)信号通路对卵巢癌大鼠免疫功能及癌细胞侵袭转移的影响。
Med Sci Monit. 2019 Jun 23;25:4655-4664. doi: 10.12659/MSM.915503.
6
Preclinical Models of Ovarian Cancer: Pathogenesis, Problems, and Implications for Prevention.卵巢癌的临床前模型:发病机制、问题及预防意义
Clin Obstet Gynecol. 2017 Dec;60(4):789-800. doi: 10.1097/GRF.0000000000000312.
7
Baseline and post prophylactic tubal-ovarian surgery CA125 levels in BRCA1 and BRCA2 mutation carriers.BRCA1 和 BRCA2 基因突变携带者预防性输卵管卵巢手术后的基线和术后 CA125 水平。
Fam Cancer. 2014 Jun;13(2):197-203. doi: 10.1007/s10689-013-9697-9.
8
Peritoneal washing cytology in patients with BRCA1 or BRCA2 mutations undergoing risk-reducing salpingo-oophorectomies: a 10-year experience and reappraisal of its clinical utility.BRCA1 或 BRCA2 基因突变患者行预防性输卵管卵巢切除术的腹腔冲洗细胞学检查:10 年经验及临床应用再评估。
Gynecol Oncol. 2012 Jun;125(3):683-6. doi: 10.1016/j.ygyno.2012.03.009. Epub 2012 Mar 13.
9
Development and validation of a protein-based signature for the detection of ovarian cancer.用于检测卵巢癌的基于蛋白质的特征标志物的开发与验证
Clin Lab Med. 2009 Mar;29(1):47-55. doi: 10.1016/j.cll.2009.02.001.
10
Risk-reducing surgery for ovarian cancer: outcomes in 300 surgeries suggest a low peritoneal primary risk.卵巢癌的降风险手术:300 例手术的结果表明腹膜原发风险较低。
Eur J Hum Genet. 2009 Nov;17(11):1381-5. doi: 10.1038/ejhg.2009.60. Epub 2009 Apr 15.